Advanced search×
×

Phase II Study of Antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in Patients With Recurrent Glioma

Mayo Clinic Proceedings 74(2):137 (1999) PMID 10069350

Objective To assess the pharmacokinetics, toxicity, and efficacy of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261).

DOI: 10.4065/74.2.137